Pediatrix Medical reports Q3 non-GAAP EPS 32c, consensus 43c

Reports Q3 revenue $507M, consensus $508.25M. “We believe the underlying fundamentals of our business remain strong, however, the third quarter was more challenged than expected with relatively soft patient volumes and persistent practice-level cost growth,” said CEO James Swift. “We are moving with speed and agility to take actions designed to enhance operating effectiveness, support and bolster our core business and generate a stable gross-margin profile.”